Genomics In Cancer Care Global Market Report 2024

Request Free Sample Buy Report

Genomics In Cancer Care Market Report 2023

Genomics In Cancer Care Global Market Report 2024 – By Product Type( Instruments, Consumables, Services), By Technology( PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies), By Application( Diagnostics, Personalized Medicine, Drug Discovery And Development, Research), By End-user( Hospitals, Government Institutes, Research Facilities) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $4000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request Sample

Request For Discount

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Genomics In Cancer Care Market Definition And Segments

Genomics in cancer care refers to the examination of all variations in DNA sequence and gene expression between tumor cells and healthy host cells to recognize the patients' genetic backgrounds to provide better cancer treatment. Genomics in cancer care is used to detect cancer-causing mutations, enhance tumor-specific diagnostic techniques and treatment plans, enable precision medicine research and drug development, and allow the development of targeted therapies to offer personalized medicines to patients suffering from various types of cancers.

The main product types of genomics in cancer care are instruments, consumables, and services. Instruments refer to devices or equipment used for the detection of tumors in cancer genomics. Instruments are used to provide accurate diagnostics in cancer genomics. The technology used are PCR, microarrays, genome sequencing and others. The applications of genomics in cancer care are diagnostics, personalized medicine, drug discovery and development, and research that are used by hospitals, government institutes, and research facilities.

The genomics in cancer care market covered in this report is segmented –

1) By Product Type: Instruments, Consumables, Services

2) By Technology: PCR (Polymerase Chain Reaction), Microarrays, Genome Sequencing, Other Technologies

3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research

4) By End-user: Hospitals, Government Institutes, Research Facilities

The genomics in cancer care market size has grown rapidly in recent years. It will grow from $15.08 billion in 2023 to $17.79 billion in 2024 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to early research and development, development of companion diagnostics, ethical and legal frameworks, data standardization and interpretation, initial market penetration.

The genomics in cancer care market size is expected to see rapid growth in the next few years. It will grow to $33.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to increasing prevalence of cancer, advancements in data analytics, market expansion in emerging economies, genomic data privacy and security, improving healthcare infrastructure. Major trends in the forecast period include technological advancements, personalized medicine, reduced costs of genomic sequencing, regulatory support and guidelines, patient awareness and demand.

The Ascendance Of Genomics In Meeting The Demand For Advanced Cancer Diagnostics

Growing demand for cancer diagnostics is expected to propel genomics in the cancer care market. Cancer diagnostics refers to identifying the right tumor kind, location, extent, and stage by tests and procedures confirming the disease's presence. Genomics in cancer care helps in determining a suitable treatment plan for cancer patients by recognizing their genetic backgrounds. For instance, in January 2021, according to the data published in ACS Journals, a US-based cancer journal for clinicians, a total of 1.8 million new cancer cases were diagnosed in the United States. Furthermore, in September 2020, the National Cancer Institute, a US-based national health institute, reported that the annual incidence of new cancer cases was 442.4 per 100,000 men and women. Therefore, the growing demand for cancer diagnostics is expected to drive genomics in the cancer care market.

Unleashing Growth Through Increased Funding And Investments In Cancer Research

Increase in funding and investments for genomics research for cancer is expected to propel the growth of the genomics in cancer care market going forward. 'Funding and investments' refer to the financial resources provided to a business, project, or initiative to support its operations, development, or expansion. The integration of genomics in cancer care has spurred significant funding and investment across the healthcare and biotechnology sectors. As the understanding of genetic factors influencing cancer continues to advance, investors are increasingly drawn to innovative companies developing cutting-edge genomics technologies. These technologies range from next-generation sequencing platforms for comprehensive genomic profiling to liquid biopsy assays that enable non-invasive monitoring of cancer progression. For instance, in December 2022, according to an article published by the gov.uk, a UK-based public sector information website, the UK government has invested around £175 million ($1.2 million) to boost the cutting-edge genomics research. The funding will enable research which could deliver world-leading genomic healthcare to patients. Therefore, an increase in funding and investments for genomics research for cancer is driving the genomics in cancer care market.

Major companies operating in the genomics in cancer care market report are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Danaher Corporation, Vyant Bio Inc., Pacific Biosciences of California Inc., Roche Holding AG, Quest Diagnostics Incorporated, DiaSorin S.p.A., BGI Group, Myriad Genetics Inc., Healthcare Global Enterprises Ltd., NeoGenomics Laboratories, Foundation Medicine Inc., Intermountain Healthcare, Laboratory Corporation of America Holdings, Flatiron Health Inc., Personal Genome Diagnostics Inc., Natera Inc., GRAIL Inc., Freenome Holdings Inc., Genomic Health Inc., Caris Life Sciences Inc., Tempus Labs Inc., OncoDNA S.A., Cancer Genetics Inc., Biocept Inc., GenomOncology Corp., OncoCyte Corporation, PathAI Inc., Enzyme Corporation, Karius Inc., N-of-One Inc., Oncora Medical Inc., Paradigm Diagnostics Inc., PierianDx Inc., Predicine Inc., Resolution Bioscience Inc., Strata Oncology Inc.

Advancements In Next-Generation Sequencing Technologies Transforming Genomics In Cancer Care

Technological advancement is a key trend gaining popularity in genomics in the cancer care market. Major market players are concentrating on creating innovative next-generation sequencing technologies to strengthen their position in the market. For instance, in December 2021, Personalis, Inc., a US-based provider of genomic sequencing and analytics solutions, launched NeXT Personal. This next-generation liquid biopsy assay considers the patient's tumor to identify and measure residual molecular disease (MRD) and cancer recurrence. It is a robust tumor-informed liquid biopsy assay that provides industry-leading MRD sensitivity in the range of 1-3 parts per million (PPM), representing a 10X-100X improvement over other available methods. This predictive biomarker extends existing tumor-informed MRD assays by simultaneously identifying and measuring clinically relevant mutations in circulating tumor DNA (ctDNA) that would one day be used to assist direct therapy when cancer is detected.

C2I Genomics And Karkinos Healthcare Forge Strategic Partnership

Major companies collaborate and get into partnerships to strengthen their position in the genomics in cancer care market. A business strategic partnership refers to a structured affiliation between two or more commercial enterprises, typically established via one or more business agreements or contracts. For instance, in June 2022, C2i Genomics, an Israel-based genomic cancer treatments company partnered with Karkinos Healthcare. The collaboration seeks to bring innovative cancer detection technology to drive R&D, future pharma partnerships and clinical use in India and supports the C2i Genomic’s long-term goals to scale pharma R&D projects around the globe. Karkinos Healthcare is an India-based technology led managed care platform for cancer.

A Boost In Cancer Diagnostics With Resolution Bioscience Acquisition

In March 2021, Agilent Technologies Inc., a US-based life sciences company, acquired Resolution Bioscience Inc. for $550 million. With this acquisition, Agilent broadens its NGS-based cancer diagnostics product portfolio and serves the needs of patients by developing innovative technologies for precision medicine using Resolution Bioscience’s non-invasive liquid biopsy assay platform. Resolution Bioscience Inc. is a US-based next-generation sequencing (NGS) technology company specializing in precision oncology technologies based on next-generation sequencing (NGS).

North America was the largest region in the genomics in cancer care market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics in cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomics in cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomics in the cancer care market consists of revenues earned by entities by providing sequencing to identify DNA and RNA alterations, and defining molecular subtypes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The genomics in cancer care market research report is one of a series of new reports from The Business Research Company that provides genomics in cancer care market statistics, including genomics in cancer care industry global market size, regional shares, competitors with a genomics in cancer care market share, detailed genomics in cancer care market segments, market trends and opportunities, and any further data you may need to thrive in the genomics in cancer care industry. This genomics in cancer care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Genomics In Cancer Care Market Report Scope

Report Attribute	Details
Market Size Value In 2024	$17.79 billion
Revenue Forecast In 2033	$33.28 billion
Growth Rate	CAGR of 17% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Product Type: Instruments, Consumables, Services 2) By Technology: PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies 3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research 4) By End-user: Hospitals, Government Institutes, Research Facilities
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled	Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V.; Bio-Rad Laboratories Inc.; Danaher Corporation; Vyant Bio Inc.; Pacific Biosciences of California Inc.; Roche Holding AG; Quest Diagnostics Incorporated; DiaSorin S.p.A.; BGI Group; Myriad Genetics Inc.; Healthcare Global Enterprises Ltd.; NeoGenomics Laboratories; Foundation Medicine Inc.; Intermountain Healthcare; Laboratory Corporation of America Holdings; Flatiron Health Inc.; Personal Genome Diagnostics Inc.; Natera Inc.; GRAIL Inc.; Freenome Holdings Inc.; Genomic Health Inc.; Caris Life Sciences Inc.; Tempus Labs Inc.; OncoDNA S.A.; Cancer Genetics Inc.; Biocept Inc.; GenomOncology Corp.; OncoCyte Corporation; PathAI Inc.; Enzyme Corporation; Karius Inc.; N-of-One Inc.; Oncora Medical Inc.; Paradigm Diagnostics Inc.; PierianDx Inc.; Predicine Inc.; Resolution Bioscience Inc.; Strata Oncology Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

Table Of Contents

1. Executive Summary

2. Genomics In Cancer Care Market Characteristics

3. Genomics In Cancer Care Market Trends And Strategies

4. Genomics In Cancer Care Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market

4.2. Ukraine-Russia War Impact On the Market

4.3. COVID-19 Impact On the Market

5. Global Genomics In Cancer Care Market Size and Growth

5.1. Global Genomics In Cancer Care Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Genomics In Cancer Care Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Genomics In Cancer Care Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Genomics In Cancer Care Market Segmentation

6.1. Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Instruments

Consumables

Services

6.2. Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

PCR (?Polymerase Chain Reaction)

MicroArrays

Genome Sequencing

Other Technologies

6.3. Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Diagnostics

Personalized Medicine

Drug Discovery And Development

Research

6.4. Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Government Institutes

Research Facilities

7. Genomics In Cancer Care Market Regional And Country Analysis

7.1. Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Genomics In Cancer Care Market

8.1. Asia-Pacific Genomics In Cancer Care Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Genomics In Cancer Care Market

9.1. China Genomics In Cancer Care Market Overview

9.2. China Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Genomics In Cancer Care Market

10.1. India Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Genomics In Cancer Care Market

11.1. Japan Genomics In Cancer Care Market Overview

11.2. Japan Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Genomics In Cancer Care Market

12.1. Australia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Genomics In Cancer Care Market

13.1. Indonesia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Genomics In Cancer Care Market

14.1. South Korea Genomics In Cancer Care Market Overview

14.2. South Korea Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Genomics In Cancer Care Market

15.1. Western Europe Genomics In Cancer Care Market Overview

15.2. Western Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Genomics In Cancer Care Market

16.1. UK Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Genomics In Cancer Care Market

17.1. Germany Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Genomics In Cancer Care Market

18.5. France Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Genomics In Cancer Care Market

19.9. Italy Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Genomics In Cancer Care Market

20.13. Spain Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Genomics In Cancer Care Market

21.1. Eastern Europe Genomics In Cancer Care Market Overview

21.2. Eastern Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Genomics In Cancer Care Market

22.1. Russia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Genomics In Cancer Care Market

23.1. North America Genomics In Cancer Care Market Overview

23.2. North America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Genomics In Cancer Care Market

24.1. USA Genomics In Cancer Care Market Overview

24.2. USA Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Genomics In Cancer Care Market

25.1. Canada Genomics In Cancer Care Market Overview

25.2. Canada Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Genomics In Cancer Care Market

26.1. South America Genomics In Cancer Care Market Overview

26.2. South America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Genomics In Cancer Care Market

27.1. Brazil Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Genomics In Cancer Care Market

28.1. Middle East Genomics In Cancer Care Market Overview

28.2. Middle East Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Genomics In Cancer Care Market

29.1. Africa Genomics In Cancer Care Market Overview

29.2. Africa Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Genomics In Cancer Care Market Competitive Landscape And Company Profiles

30.1. Genomics In Cancer Care Market Competitive Landscape

30.2. Genomics In Cancer Care Market Company Profiles

30.2.1. Illumina Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Thermo Fisher Scientific Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Agilent Technologies Inc.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. PerkinElmer Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. QIAGEN N.V

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Global Genomics In Cancer Care Market Competitive Benchmarking

32. Global Genomics In Cancer Care Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Genomics In Cancer Care Market

34. Genomics In Cancer Care Market Future Outlook and Potential Analysis

34.1 Genomics In Cancer Care Market In 2028 - Countries Offering Most New Opportunities

34.2 Genomics In Cancer Care Market In 2028 - Segments Offering Most New Opportunities

34.3 Genomics In Cancer Care Market In 2028 - Growth Strategies

34.3.1 Market Trend Based Strategies

34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations

35.2. Currencies

35.3. Historic And Forecast Inflation Rates

35.4. Research Inquiries

35.5. The Business Research Company

35.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Illumina Inc. Financial Performance

Table 76: Thermo Fisher Scientific Inc. Financial Performance

Table 77: Agilent Technologies Inc. Financial Performance

Table 78: PerkinElmer Inc. Financial Performance

Table 79: QIAGEN N.V Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Illumina Inc. Financial Performance

Figure 76: Thermo Fisher Scientific Inc. Financial Performance

Figure 77: Agilent Technologies Inc. Financial Performance

Figure 78: PerkinElmer Inc. Financial Performance

Figure 79: QIAGEN N.V Financial Performance

Global Dairy Food Market Opportunities And Strategies – Forecast To 2030 – Includes Dairy Food Industry

Global Meat Products Market Opportunities And Strategies – Forecast To 2030 – Includes Meat Products Market Report

Global Organic Poultry Market Opportunities And Strategies – Forecast To 2030 – Includes Organic Poultry Market Growth

Global Functional Food Market Opportunities And Strategies – Forecast To 2030 – Includes Functional Food Market Size

The Business Research Company offers the cattle feed market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the amla extract market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the grain alcohol market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the coffee and tea market research report 2022 with industry size, share, segments and market growth

Cancer biologics Global Market Report 2024 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer Diagnostics Global Market Report 2024 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Genomics Global Market Report 2024 – By Product Type (Instrument (Including Systems, Service Contract And Software), Reagents (Including Reagents And Consumables)), By Process (Cell Isolation, Sample Preparation, Genomic Analysis), By End User (Academic Institutes, Biopharmaceutical Companies, Clinical Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer Monoclonal Antibodies Global Market Report 2024 – By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others), By End-User (Hospitals, Research Laboratories, Others) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cancer Vaccines Global Market Report 2024 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Interventional Oncology Devices Global Market Report 2024 – By Product (Embolization Devices, Ablation Devices, Support Devices), By procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT), Transcatheter Arterial Embolization (TAE), Bland Embolization), By Cancer Type (Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other Cancer Types) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Influenza Diagnostic Global Market Report 2024 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests), By Molecular diagnostic tests (Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests), By End User (Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Industrial Land Planning And Development Global Market Report 2024 – By Type (Industrial Developments, and Other Developments), By Industry (Residential, and Organization) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the genomics in cancer care market?

How will the genomics in cancer care market drivers and restraints affect the genomics in cancer care market dynamics? What forces will shape the genomics in cancer care industry going forward?

The genomics in cancer care market major growth driver - the ascendance of genomics in meeting the demand for advanced cancer diagnostics. For further insights on the genomics in cancer care market, request a sample here

What is the forecast market size or the forecast market value of the genomics in cancer care market ?

The genomics in cancer care market size has grown rapidly in recent years. It will grow from $15.08 billion in 2023 to $17.79 billion in 2024 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to early research and development, development of companion diagnostics, ethical and legal frameworks, data standardization and interpretation, initial market penetration. The genomics in cancer care market size is expected to see rapid growth in the next few years. It will grow to $33.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to increasing prevalence of cancer, advancements in data analytics, market expansion in emerging economies, genomic data privacy and security, improving healthcare infrastructure. Major trends in the forecast period include technological advancments, personalized medicine, reduced costs of genomic sequencing, regulatory support and guidelines, patient awareness and demand. For further insights on the genomics in cancer care market, request a sample here

How is the genomics in cancer care market segmented?

The genomics in cancer care market is segmentedThe genomics in cancer care market covered in this report is segmented –
1) By Product Type: Instruments, Consumables, Services
2) By Technology: PCR (?Polymerase Chain Reaction), MicroArrays, Genome Sequencing, Other Technologies
3) By Application: Diagnostics, Personalized Medicine, Drug Discovery And Development, Research
4) By End-user: Hospitals, Government Institutes, Research FacilitiesFor further insights on the genomics in cancer care market, request a sample here

Which region has the largest share of the genomics in cancer care market? What are the other regions covered in the report?

North America was the largest region in the genomics in cancer care market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics in cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the genomics in cancer care market, request a sample here.

Who are the major players in the genomics in cancer care market?

What are the key trends in the genomics in cancer care market?

Major trend in the genomics in cancer care market - advancements in next-generation sequencing technologies transforming genomics in cancer care. For further insights on the genomics in cancer care market, request a sample here.

What are the major opportunities in the genomics in cancer care market? What are the strategies for the genomics in cancer care market?

For detailed insights on the major opportunities and strategies in the genomics in cancer care market, request a sample here.

How does the genomics in cancer care market relate to the overall economy and other similar markets?

For detailed insights on genomics in cancer care market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the genomics in cancer care industry?

For detailed insights on the mergers and acquisitions in the genomics in cancer care industry, request a sample here.

What are the key dynamics influencing the genomics in cancer care market growth? SWOT analysis of the genomics in cancer care market.

For detailed insights on the key dynamics influencing the genomics in cancer care market growth and SWOT analysis of the genomics in cancer care industry, request a sample here.